Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma

Signal Transduct Target Ther. 2023 Feb 10;8(1):61. doi: 10.1038/s41392-022-01262-x.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Hepatocellular* / genetics
  • Gene Expression Profiling
  • Humans
  • Liver Neoplasms* / genetics
  • Transcriptome / genetics